The Department of Justice claimed CVS retail pharmacies in Rhode Island filled forged prescriptions with invalid DEA numbers and filled prescriptions written by psychiatric nurse practitioners for hydrocodone, even though the practitioners were not legally permitted to prescribe them. The DOJ also accused CVS of recordkeeping deficiencies.
The alleged act is a violation of the federal Controlled Substances Act, which states substances such as painkillers and opioids can only be prescribed for medical purposes by a physician. In addition, the law puts a “corresponding responsibility” on the pharmacist filling the prescription to ensure the prescription is valid and legal, and the prescriber has the legal authority to prescribe the drug.
Although CVS will pay the $450,000 civil settlement, it denies wrongdoing in this case.
More articles on legal and regulatory issues:
Union files lawsuit to block privatization of Maui’s hospitals: 5 things to know
CHS subsidiary sues Georgia hospital for $5M over failed transaction
Court issues first False Claims Act 60-day repayment rule decision: 5 takeaways
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
